The total confirmed ko with 19 infections in India
moving closer to 44lakh after nearly 90 000 cases were reported in the last 24 hours
active cases now stand at almost 9 lakh record of nearly 75000 people recovered
yesterday taking total recoveries closer to 34 lakh for the eighth straight day
India has reported more than a thousand deaths taking the overall toll near 74
000 with over two lakh confirmed infections in pune has overtaken Delhi as the worst
affected city pune.
the most active cases in the country at the moment Bangalore
is just below Mumbai and above thane with over 1.5 lakh confirmed cases and
here's the latest in the hunt for a Kobe 19 vaccine the phase three trial of
the oxford asteroids Anika covet vaccine candidate has been put on pause in the
united kingdom the trial has been halted overnight quote a potentially
unexplained illness pending a review this comes days after
Aston unica along
with eight other farmer giants took a pledge to uphold scientific and ethical
standards in the search for and ethical meg Tyrel joins us now with the details
menthe company's large phase 3 clinical trial of its covert 19 vaccine has been
put on a clinical hold due to vaccine has safety reaction and one of the
participants in the trial in the know I’ve reached out to AstraZeneca and
haven’t yet heard back for confirmation although state news says that a
spokesperson for the company said quote it was a standard review process that
triggered a positive vaccination to allow review of acetylates it's not clear
exactly what this safety event was how long this pause could potentially last
or you know how effective how much of an effect this will really have on the
trial going forward but Melissa this is really the first snafu we’ve seen in an
incredibly sped-up vaccine development process for multiple for multiple of
course is one of the front-runners in the vaccine race it just started its
phase 3 trial.
In the united states as well after starting it around the world it’s behind Pfizer and modern and it does have a different technology from both of those companies many thanks for joining us so that is the latest oxford zamia putting theatrical on hold meanwhile serum institute the Indian partner for the Indian vaccine candidate has told the trials in India have not been put on pause in separate news a study by the incur the center’s apex medical body has found that plasma therapy for Covid-19 has no benefit either in reducing mortality or arresting the progression of the virus joining us now to talk about this and more is dry ran deep galleria the director of the all India institute of medical sciences in the capital dry galleria many thanks for joining us here on let me start by asking you about the news that's coming from the up where the oxford AstraZeneca trial has been put on pause because of an unexplained illness in the trial serum institute telling that the trial in India has not been stopped it has not been paused now you’ve been uh involved with both the serum trial which is for the Indian vaccine as well as the biotech vaccine.
what can you tell us I think as we do study safety is paramount trial for vaccine studies we are looking at two things safety and efficacy but of the two the most important thing is the safe vaccine and this is implication in the long run because currently as far as the trials are concerned these are normal healthy people who are these are you could have side effects which could be vaccine related or which could be unrelated after all people could help other illnesses which happened while you have been vaccinated.
So I think if some side effects is important to be able to differentiates this a vaccine related event or is it an event which has occurred which could be incidental and not related to the vaccine but since these are vaccines that we ‘retrying in which we are going to begiving subsequently to a large population 50 is paramount and therefore even if there's a slight doubt it’s very important that that be clarified the data safety monitoring board will look into this and within a few days they will be abalone way or the other and based on that it will mean that the decision is taken.
How to take it forward yes you're absolutely right that safety is of utmost importance since this is a vaccine that will be administered to healthy individuals but dry galleria can you tell us about the status of both the trials biotech as well as thereinto trial underway for serums koi shields as far as the trials are concerned the biotech trial is now well into phase two and we've seen the initial data is good as far as safety is concerned we're now looking at is concerned how effective the vaccine is and I’m hopeful that that data should I’m hopeful and we would move into the phase three trial actually where we would be vaccinating a large number of individuals to see for any signals as far as side effects are concerned and also seeing in real life situation
0 Comments